Korea Hip Replacement Surgery Registry

Hip Replacement Surgery Clinical Trial

Official title:

Efficacy and Safety of Hip Replacement Surgery Using Korean National Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06307145
• Other study ID #: K-NHIS-HIP
• Status: Completed
• Start date: January 1, 2003
• Est. completion date: December 31, 2020

Study information

• Verified date: March 2024
• Source: Samsung Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner.

Description:

This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner. The safety issues included the incidence of cancer, orthoperiodic outcome (dislocation, mechanical Cx, periprosthetic join infection, periprosthetic fracture), revision, embolism or thrombosis, cardiac outcome, and death

Recruitment information / eligibility

• Status: Completed
• Enrollment: 124556
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Patient aged 19 or older who received hip replacement surgery

Exclusion Criteria:

• Insufficient information

• history of any revision

Related Conditions & MeSH terms

• Hip Replacement Surgery

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Samsung Medical Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cancer	Incidence of cancer	the occurrence of cancer, death, or December 31st, 2019 (end of the study), whichever came first.